DK1551805T3 - Substituerede gamma phenyl delta lactamer og dertil knyttede anvendelser - Google Patents
Substituerede gamma phenyl delta lactamer og dertil knyttede anvendelserInfo
- Publication number
- DK1551805T3 DK1551805T3 DK03753187.8T DK03753187T DK1551805T3 DK 1551805 T3 DK1551805 T3 DK 1551805T3 DK 03753187 T DK03753187 T DK 03753187T DK 1551805 T3 DK1551805 T3 DK 1551805T3
- Authority
- DK
- Denmark
- Prior art keywords
- lactamer
- delta
- related applications
- substituted gamma
- phenyl
- Prior art date
Links
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/263,336 US6770658B2 (en) | 1998-09-09 | 2002-10-01 | Substituted γ-phenyl-Δ-lactams and uses related thereto |
PCT/CA2003/001506 WO2004031149A1 (en) | 2002-10-01 | 2003-09-30 | Substituted gamma-phenyl-delta-lactams and uses related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1551805T3 true DK1551805T3 (da) | 2013-04-15 |
Family
ID=32068272
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03753187.8T DK1551805T3 (da) | 2002-10-01 | 2003-09-30 | Substituerede gamma phenyl delta lactamer og dertil knyttede anvendelser |
Country Status (12)
Country | Link |
---|---|
US (1) | US6770658B2 (da) |
EP (1) | EP1551805B1 (da) |
JP (1) | JP4768989B2 (da) |
AU (1) | AU2003271478B2 (da) |
CA (1) | CA2500675C (da) |
CY (1) | CY1114133T1 (da) |
DK (1) | DK1551805T3 (da) |
ES (1) | ES2409333T3 (da) |
MX (1) | MXPA05003547A (da) |
PT (1) | PT1551805E (da) |
SI (1) | SI1551805T1 (da) |
WO (1) | WO2004031149A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6770658B2 (en) * | 1998-09-09 | 2004-08-03 | Inflazyme Pharmaceuticals Ltd. | Substituted γ-phenyl-Δ-lactams and uses related thereto |
US20080051379A1 (en) * | 2004-12-01 | 2008-02-28 | Trustees Of Boston University | Compositions and Methods for the Treatment of Peripheral B-Cell Neoplasms |
WO2006062817A2 (en) * | 2004-12-01 | 2006-06-15 | Boston Medical Center Corporation | Compositions and methods for the treatment of peripheral b-cell neoplasms |
GB0722769D0 (en) * | 2007-11-21 | 2008-01-02 | Biolipox Ab | New compounds |
JP2010521444A (ja) * | 2007-03-12 | 2010-06-24 | バイオリポックス エービー | 炎症の治療において有用なピペリジノン類 |
CA2730940A1 (en) * | 2008-07-18 | 2010-01-21 | Dart Neuroscience Llc | Methods and systems for evaluating memory agents |
WO2011114103A1 (en) | 2010-03-18 | 2011-09-22 | Biolipox Ab | Pyrimidinones for use as medicaments |
RU2573636C2 (ru) * | 2010-05-31 | 2016-01-27 | Бриджстоун Корпорейшн | Содержащий гидроксильные группы метилстирол и полимеры на его основе |
JO2998B1 (ar) | 2010-06-04 | 2016-09-05 | Amgen Inc | مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان |
WO2013036861A1 (en) | 2011-09-08 | 2013-03-14 | Codexis, Inc | Biocatalysts and methods for the synthesis of substituted lactams |
CA2850166C (en) | 2011-09-27 | 2019-12-03 | Amgen Inc. | Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer |
US8883857B2 (en) | 2012-12-07 | 2014-11-11 | Baylor College Of Medicine | Small molecule xanthine oxidase inhibitors and methods of use |
US11407721B2 (en) | 2013-02-19 | 2022-08-09 | Amgen Inc. | CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer |
EP2961735B1 (en) | 2013-02-28 | 2017-09-27 | Amgen Inc. | A benzoic acid derivative mdm2 inhibitor for the treatment of cancer |
MX2015012427A (es) | 2013-03-14 | 2016-01-12 | Amgen Inc | Compuestos de morfolinona de acido heteroarilo como inhibidores mdm2 para el tratamiento de cancer. |
JOP20200296A1 (ar) | 2013-06-10 | 2017-06-16 | Amgen Inc | عمليات صنع وأشكال بلورية من mdm2 مثبط |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3607885A (en) | 1968-08-15 | 1971-09-21 | Universal Oil Prod Co | Preparation of lactones such as substituted delta valerolactones |
US3565904A (en) | 1969-01-31 | 1971-02-23 | Bristol Myers Co | 1,2,3,4-tetrahydro-1-naphthoic acids |
US3718743A (en) | 1970-11-19 | 1973-02-27 | Merck & Co Inc | 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones in compositions and methods for treating pain, fever and inflammation |
US3814771A (en) | 1970-11-19 | 1974-06-04 | T Shen | 5-phenyl-2-piperidones and 5-phenyl-2-thiopiperidones |
DK116181A (da) | 1980-04-11 | 1981-10-12 | Hoffmann La Roche | Fremgangsmaade til fremstilling af quinolizidinderivater |
ZA821888B (en) | 1981-04-01 | 1983-02-23 | Haessle Ab | Novel phenyl-piperidines |
US4616089A (en) | 1983-08-03 | 1986-10-07 | University Of California | Synthetic anti-inflammatory derivatives of manoalide |
DE3579723D1 (de) | 1984-04-02 | 1990-10-25 | Daicel Chem | Aliphatische oder aromatische polysaccharidester enthaltendes trennungsmittel. |
DE3438839A1 (de) * | 1984-10-19 | 1986-04-24 | Schering AG, 1000 Berlin und 4709 Bergkamen | Pharmazeutische praeparate |
US4838925A (en) | 1986-04-25 | 1989-06-13 | E. I. Du Pont De Nemours And Company | Heterocyclic acyl sulfonamides |
DE4005516A1 (de) | 1989-02-24 | 1990-08-30 | Henkel Corp | Verfahren zur umwandlung (alpha)-acetyl-substituierter lactone in (alpha)-alkyliden-substituierte lactone |
US5416224A (en) | 1989-02-24 | 1995-05-16 | Henkel Corporation | Process for converting α-acyl-substituted lactones to α-alkylidene-substituted lactones |
DE4005515A1 (de) | 1989-02-24 | 1990-08-30 | Henkel Corp | Verfahren zur herstellung von (alpha)-alkyllactonen |
US5231192A (en) | 1989-02-24 | 1993-07-27 | Henkel Corporation | Process for the preparation of alpha-alkyl lactones |
DE69231854T2 (de) | 1991-04-17 | 2001-10-04 | Pharmacia & Upjohn Co., Kalamazoo | Substituierte (s)-3-phenylpiperidin derivate, deren herstellung und deren verwendung als dopamin autorezeptor antagonisten |
WO1992020738A1 (en) | 1991-05-21 | 1992-11-26 | Battelle Memorial Institute | Degradable cellulose polymers |
DE4125457A1 (de) | 1991-08-01 | 1993-02-04 | Bayer Ag | Verfahren zur herstellung von n-substituierten lactamen |
US5234933A (en) | 1991-10-31 | 1993-08-10 | Board Of Governors Of Wayne State University And Vanderbilt University | Cyclic hydroxamic acids |
JP3101053B2 (ja) | 1992-02-07 | 2000-10-23 | 株式会社共立 | 新規化合物及び該化合物を含有するマツノザイセンチュウ殺線虫剤 |
IL105168A0 (en) | 1992-04-03 | 1993-07-08 | Lilly Co Eli | Heteroannulation process |
JPH06157459A (ja) | 1992-11-16 | 1994-06-03 | Eezai Kagaku Kk | ピリジルケトアルコールの製造法 |
US5478356B1 (en) | 1994-05-10 | 1997-11-18 | Clorox Co | Cyanoimides and compositions useful for bleaching |
US5629429A (en) | 1995-06-07 | 1997-05-13 | Bristol-Myers Squibb Company | Process for preparing 4-arylamino-benzopyran and related compounds |
DE19541012A1 (de) | 1995-11-03 | 1997-05-07 | Basf Ag | Verwendung von Oximestern als Aktivatoren für anorganische Perverbindungen |
AU7692896A (en) | 1995-12-01 | 1997-06-27 | Novartis Ag | Quinazolin-2,4-diazirines as NPY receptor antagonist |
DE19603477A1 (de) | 1996-01-31 | 1997-08-07 | Klaus Dr Med Reuter | Tumormittel |
ATE272628T1 (de) | 1998-09-09 | 2004-08-15 | Inflazyme Pharm Ltd | Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen |
US6770658B2 (en) * | 1998-09-09 | 2004-08-03 | Inflazyme Pharmaceuticals Ltd. | Substituted γ-phenyl-Δ-lactams and uses related thereto |
-
2002
- 2002-10-01 US US10/263,336 patent/US6770658B2/en not_active Expired - Lifetime
-
2003
- 2003-09-30 SI SI200332267T patent/SI1551805T1/sl unknown
- 2003-09-30 ES ES03753187T patent/ES2409333T3/es not_active Expired - Lifetime
- 2003-09-30 JP JP2004540421A patent/JP4768989B2/ja not_active Expired - Fee Related
- 2003-09-30 DK DK03753187.8T patent/DK1551805T3/da active
- 2003-09-30 WO PCT/CA2003/001506 patent/WO2004031149A1/en active Application Filing
- 2003-09-30 PT PT37531878T patent/PT1551805E/pt unknown
- 2003-09-30 CA CA2500675A patent/CA2500675C/en not_active Expired - Fee Related
- 2003-09-30 AU AU2003271478A patent/AU2003271478B2/en not_active Ceased
- 2003-09-30 EP EP03753187A patent/EP1551805B1/en not_active Expired - Lifetime
- 2003-09-30 MX MXPA05003547A patent/MXPA05003547A/es active IP Right Grant
-
2013
- 2013-04-10 CY CY20131100300T patent/CY1114133T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT1551805E (pt) | 2013-04-11 |
CA2500675C (en) | 2011-09-13 |
ES2409333T3 (es) | 2013-06-26 |
US20030186943A1 (en) | 2003-10-02 |
CA2500675A1 (en) | 2004-04-15 |
EP1551805B1 (en) | 2013-04-03 |
JP4768989B2 (ja) | 2011-09-07 |
SI1551805T1 (sl) | 2013-07-31 |
AU2003271478A1 (en) | 2004-04-23 |
EP1551805A1 (en) | 2005-07-13 |
AU2003271478B2 (en) | 2010-03-04 |
US6770658B2 (en) | 2004-08-03 |
JP2006508069A (ja) | 2006-03-09 |
CY1114133T1 (el) | 2016-07-27 |
MXPA05003547A (es) | 2005-07-01 |
WO2004031149A1 (en) | 2004-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018009I2 (el) | Παραλλαγες ανοσοσφαιρινων και χρησεις αυτων | |
DK2418220T3 (da) | Interferon-alpha-antistoffer og anvendelser deraf | |
DK1478648T3 (da) | Phosphorholdige forbindelser og anvendelser deraf | |
DE60229169D1 (de) | Kühlvorrichtung | |
DK1513873T3 (da) | Terapeutiske epitoper og anvendelser deraf | |
DK3025726T3 (da) | Polyalkylenpolymerforbindelser og anvendelser deraf | |
DE60326611D1 (de) | N und dergleichen | |
NO20033456L (no) | Modifiserte og stabiliserte GDF-propeptider og anvendelse derav | |
DE60231431D1 (de) | Ement | |
DE60315429D1 (de) | Gehäuse | |
NO20055568D0 (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
DK1551805T3 (da) | Substituerede gamma phenyl delta lactamer og dertil knyttede anvendelser | |
DK1484347T3 (da) | Harpikssammensætning og optiske elementer | |
IS7594A (is) | Laxófoxifen tafla og húðun hennar | |
DK1489117T3 (da) | Harpikssammensætning og optisk element | |
DK1814977T3 (da) | Arthrospira-baserede sammensætninger og anvendelser deraf | |
DK1675852T3 (da) | Heterocykliske 7-amino-alkylidenyl-quinoloner og -naphthyridoner | |
DE60330269D1 (de) | Piperazinyl- und diazapanylbenzamide und-benzothioamide | |
IS7783A (is) | Flóð og fjöru-ker | |
DK1601744T3 (da) | Forgasningsapparat og fremgangsmåde | |
DK1562918T3 (da) | Substituerede benzoxazinoner og anvendelser deraf | |
DK1654353T3 (da) | Tumorcellelinjerne nm-f9 (dsm acc2606) og nm-d4 (dsm acc2605) samt anvendelser deraf | |
FIU20020100U0 (fi) | Päällys | |
DE60334519D1 (de) | Kühlvorrichtung | |
DE60318139D1 (de) | Isolator- und Anordnungskonfiguration |